AstraZeneca’s licensing agreement for Tralokinumab, Brodalumab with Leo Pharma
Tralokinumab Licesning Deal: AstraZeneca pacts with licensing agreements covering two of its drug candidates with Leo Pharma, giving it global rights to skin disease... Read More
AstraZeneca and Valeant Pharmaceuticals to partner on brodalumab
AstraZeneca has entered into a collaboration agreement with Valeant Pharmaceuticals International, Inc. under which it will grant an exclusive license for Valeant... Read More